Implementation Grant Funding Opportunity Open
IMPORTANT: The grant program operates on a rolling basis and applications may be submitted at any time, with quarterly reviews.
Learn More
Implementation Grant Funding Opportunity Open
Qualifying* small and medium-sized US manufacturers, that received IAC or Combined Heat and Power Technical Assistance Partnership assessments between 2018 and 2024, can now apply for grants for implementation of assessment recommendations up 50% of qualifying* project costs with a maximum of $300,000 per manufacturer.
IMPORTANT: The grant program now operates on a rolling basis and applications may be submitted at any time through the year, with quarterly reviews.
*See Full Grant Solicitation for full qualification and selection details.
14
matching assessmentsNAICS | 32541 | Pharmaceutical and Medicine Manufacturing |
---|
ID | Year | Products | Reccs | Plant Energy Costs | Recommended Savings |
---|---|---|---|---|---|
SF0623 | 2024 |
SF0623 | 2024
Synthetic Peptides
|
5 | $186,119 | $16,345 |
SD0629 | 2023 |
SD0629 | 2023
Processed Plasma
|
5 | $513,576 | $73,378 |
SD0626 | 2023 |
SD0626 | 2023
Antibodies, Cell Therapies
|
6 | $1,515,916 | $238,831 |
SD0625 | 2023 |
SD0625 | 2023
Antibodies, Cell Therapies
|
5 | $562,294 | $112,789 |
SD0572 | 2018 |
SD0572 | 2018
Medical reagents
|
5 | $917,637 | $100,384 |
SD0545 | 2017 |
SD0545 | 2017
Generic Liquid OTC Drug Products
|
6 | $516,493 | $36,538 |
SD0500 | 2015 |
SD0500 | 2015
pills and tablets
|
7 | $2,324,159 | $457,355 |
SF0427 | 2013 |
SF0427 | 2013
Lab Test Data
|
9 | $769,900 | $21,768 |
SF0378 | 2009 |
SF0378 | 2009
Dermalogical pharmaceuticals
|
8 | $602,057 | $53,407 |
SD0413 | 2009 |
SD0413 | 2009
Biopharmaceuticals
|
12 | $1,944,781 | $370,368 |
SF0340 | 2007 |
SF0340 | 2007
Pharmaceutical Intermediates
|
18 | $3,107,800 | $549,611 |
SF0337 | 2007 |
SF0337 | 2007
Drugs of Abuse Test Kits
|
7 | $322,052 | $69,006 |
SF0336 | 2006 |
SF0336 | 2006
Drugs of Abuse Test Kits
|
13 | $673,492 | $31,471 |
LM0046 | 2003 |
LM0046 | 2003
pharmaceutical products
|
13 | $2,139,036 | $616,603 |